Company / EPS (Diluted)
Scholar Rock Holding Corp EPS (Diluted) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.47
FY2025
5-year range
-$3.59 / -$2.26
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#140 of 204
Health Care
What the data says
At $-2.47, Scholar Rock Holding Corp's eps (diluted) ranks #140 of 204 in the Health Care sector. EPS (Diluted) has fluctuated over the past 8 years, ranging from $-15.30 in FY2018 to $-1.85 in FY2020.
Based on SEC 10-K filings.
-2.47 in FY2025.
Declined from $-2.26 to $-2.47 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#140 of 204 in Health CareTop 69% of 204This company -$2.47 Sector average -$0.89
▼
-178.7% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 0.0% year-over-year.
- Ranks #140 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2020.
- Lowest eps (diluted) in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.47 | +0.0% |
| FY2024 | -$2.47 | -9.3% |
| FY2023 | -$2.26 | +37.0% |
| FY2022 | -$3.59 | -27.8% |
| FY2021 | -$2.81 | -51.9% |
| FY2020 | -$1.85 | +41.3% |
| FY2019 | -$3.15 | +79.4% |
| FY2018 | -$15.30 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026